As of 2025-07-01, the Intrinsic Value of Abb Ltd (ABBN.SW) is 34.92 CHF. This ABBN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 47.31 CHF, the upside of Abb Ltd is -26.20%.
The range of the Intrinsic Value is 24.13 - 65.20 CHF
Based on its market price of 47.31 CHF and our intrinsic valuation, Abb Ltd (ABBN.SW) is overvalued by 26.20%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 24.13 - 65.20 | 34.92 | -26.2% |
DCF (Growth 10y) | 28.75 - 73.04 | 40.47 | -14.5% |
DCF (EBITDA 5y) | 19.33 - 30.07 | 23.88 | -49.5% |
DCF (EBITDA 10y) | 23.94 - 36.78 | 29.30 | -38.1% |
Fair Value | 44.76 - 44.76 | 44.76 | -5.39% |
P/E | 29.56 - 34.89 | 31.56 | -33.3% |
EV/EBITDA | 16.82 - 34.23 | 22.65 | -52.1% |
EPV | 18.12 - 26.33 | 22.22 | -53.0% |
DDM - Stable | 18.31 - 65.01 | 41.66 | -11.9% |
DDM - Multi | 22.35 - 60.98 | 32.63 | -31.0% |
Market Cap (mil) | 87,234.91 |
Beta | 1.24 |
Outstanding shares (mil) | 1,843.90 |
Enterprise Value (mil) | 89,892.38 |
Market risk premium | 5.10% |
Cost of Equity | 6.66% |
Cost of Debt | 4.25% |
WACC | 6.46% |